Dr Joanne Simpson

  • Honorary Clinical Lecturer (School of Cardiovascular & Metabolic Health)

Publications

List by: Type | Date

Jump to: 2024 | 2023 | 2021 | 2020 | 2019 | 2018 | 2016 | 2015 | 2014
Number of items: 17.

2024

Osmanska, J., Jackson, A. M., Simpson, J., Adamson, C., Doherty, D., Mamet, H., Moir, L., Walker, N. L., Hogg, D. and Simpson, M. (2024) Preconception counselling in women of reproductive age attending cardiology clinics in Scotland. Heart, 110(13), pp. 908-915. (doi: 10.1136/heartjnl-2023-323666) (PMID:38627021)

McDowell, K. et al. (2024) Prognostic models for mortality and morbidity in heart failure with preserved ejection fraction. JAMA Cardiology, 9(5), 457. (doi: 10.1001/jamacardio.2024.0284) (PMID:38536153)

2023

McDowell, K. et al. (2023) Incremental prognostic value of biomarkers in PARADIGM-HF. European Journal of Heart Failure, 28(8), 1406-1414-1406-1414. (doi: 10.1002/ejhf.2887) (PMID:37191207)

2021

Codina, P. et al. (2021) Head‐to‐head comparison of contemporary heart failure risk scores. European Journal of Heart Failure, 23(12), pp. 2035-2044. (doi: 10.1002/ejhf.2352) (PMID:34558158)

Simpson, J. et al. (2021) Adherence to prescribed medications in patients with heart failure – insights from liquid chromatography-tandem mass spectrometry-based urine analysis. European Heart Journal: Cardiovascular Pharmacotherapy, 7(4), pp. 296-301. (doi: 10.1093/ehjcvp/pvaa071) (PMID:32597982) (PMCID:PMC8302254)

Lee, M. M.Y. et al. (2021) Invasive versus medically managed acute coronary syndromes with prior bypass (CABG-ACS): insights into the registry versus randomised trial populations. Open Heart, 8(1), e001453. (doi: 10.1136/openhrt-2020-001453) (PMID:33637568) (PMCID:PMC7919592)

2020

Simpson, J. et al. (2020) Prognostic models derived in PARADIGM-HF and validated in ATMOSPHERE and the Swedish Heart Failure Registry to predict mortality and morbidity in chronic heart failure. JAMA Cardiology, 5(4), pp. 432-441. (doi: 10.1001/jamacardio.2019.5850) (PMID:31995119)

2019

Lee, M. M.Y. et al. (2019) Invasive versus medical management in patients with prior coronary artery bypass surgery with a non-ST segment elevation acute coronary syndrome: a pilot randomized controlled trial. Circulation: Cardiovascular Interventions, 12(8), e007830. (doi: 10.1161/CIRCINTERVENTIONS.119.007830) (PMID:31362541)

Balmforth, C. et al. (2019) Outcomes and effect of treatment according to etiology in HFrEF: an analysis of PARADIGM-HF. JACC: Heart Failure, 7(6), pp. 457-465. (doi: 10.1016/j.jchf.2019.02.015) (PMID:31078482)

Simpson, J., Benson, L., Jhund, P.S. , Dahlström, U., McMurray, J.J.V. and Lund, L.H. (2019) "Real world" eligibility for sacubitril/valsartan in unselected heart failure patients: data from the Swedish Heart Failure Registry. Cardiovascular Drugs and Therapy, 33(3), pp. 315-322. (doi: 10.1007/s10557-019-06873-1) (PMID:30903545) (PMCID:PMC6538576)

2018

Simpson, J. and McMurray, J. J.V. (2018) Prognostic modeling in heart failure: time for a reboot. JACC: Heart Failure, 6(6), pp. 463-464. (doi: 10.1016/j.jchf.2018.03.020) (PMID:29852930)

Lupón, J. et al. (2018) Barcelona Bio-HF Calculator Version 2.0: incorporation of angiotensin II receptor blocker neprilysin inhibitor (ARNI) and risk for heart failure hospitalization. European Journal of Heart Failure, 20(5), pp. 938-940. (doi: 10.1002/ejhf.949) (PMID:28949101)

Lee, M. M.Y. et al. (2018) Non-Invasive Versus Invasive Management in Patients With Prior Coronary Artery Bypass Surgery With a Non-ST Segment Elevation Acute Coronary Syndrome: Comparisons Between the Randomized Controlled Pilot Trial and Registry. ACC.18, Orlando, FL, USA, 10-12 Mar 2018. A45. (doi: 10.1016/S0735-1097(18)30586-2)

Lee, M. M.Y. et al. (2018) Routine Non-invasive vs Invasive Management in Patients With Prior CABG With a NSTE-ACS: a Randomised Controlled Trial. British Cardiovascular Intervention Society Young Investigator Award Shortlisted Presentations, London, UK, 30 Nov 2017. A5.2-A6. (doi: 10.1136/heartjnl-2018-BCIS.9)

2016

Lee, M. M.Y. et al. (2016) Non-invasive versus invasive management in patients with prior coronary artery bypass surgery with a non-ST segment elevation acute coronary syndrome: study design of the pilot randomised controlled trial and registry (CABG-ACS). Open Heart, 3(1), e000371. (doi: 10.1136/openhrt-2015-000371) (PMID:27110377) (PMCID:PMC4838768)

2015

Simpson, J. et al. (2015) Comparing LCZ696 with Enalapril according to baseline risk using the MAGGIC and EMPHASIS-HF risk scores. Journal of the American College of Cardiology, 66(19), pp. 2059-2071. (doi: 10.1016/j.jacc.2015.08.878) (PMID:26541915)

2014

Simpson, J., Jackson, C. E. and Gardner, R. S. (2014) Biomarkers in mechanical circulatory support. Biomarkers in Medicine, 8(6), pp. 855-869. (doi: 10.2217/BMM.14.55)

This list was generated on Thu Sep 26 13:04:30 2024 BST.
Number of items: 17.

Articles

Osmanska, J., Jackson, A. M., Simpson, J., Adamson, C., Doherty, D., Mamet, H., Moir, L., Walker, N. L., Hogg, D. and Simpson, M. (2024) Preconception counselling in women of reproductive age attending cardiology clinics in Scotland. Heart, 110(13), pp. 908-915. (doi: 10.1136/heartjnl-2023-323666) (PMID:38627021)

McDowell, K. et al. (2024) Prognostic models for mortality and morbidity in heart failure with preserved ejection fraction. JAMA Cardiology, 9(5), 457. (doi: 10.1001/jamacardio.2024.0284) (PMID:38536153)

McDowell, K. et al. (2023) Incremental prognostic value of biomarkers in PARADIGM-HF. European Journal of Heart Failure, 28(8), 1406-1414-1406-1414. (doi: 10.1002/ejhf.2887) (PMID:37191207)

Codina, P. et al. (2021) Head‐to‐head comparison of contemporary heart failure risk scores. European Journal of Heart Failure, 23(12), pp. 2035-2044. (doi: 10.1002/ejhf.2352) (PMID:34558158)

Simpson, J. et al. (2021) Adherence to prescribed medications in patients with heart failure – insights from liquid chromatography-tandem mass spectrometry-based urine analysis. European Heart Journal: Cardiovascular Pharmacotherapy, 7(4), pp. 296-301. (doi: 10.1093/ehjcvp/pvaa071) (PMID:32597982) (PMCID:PMC8302254)

Lee, M. M.Y. et al. (2021) Invasive versus medically managed acute coronary syndromes with prior bypass (CABG-ACS): insights into the registry versus randomised trial populations. Open Heart, 8(1), e001453. (doi: 10.1136/openhrt-2020-001453) (PMID:33637568) (PMCID:PMC7919592)

Simpson, J. et al. (2020) Prognostic models derived in PARADIGM-HF and validated in ATMOSPHERE and the Swedish Heart Failure Registry to predict mortality and morbidity in chronic heart failure. JAMA Cardiology, 5(4), pp. 432-441. (doi: 10.1001/jamacardio.2019.5850) (PMID:31995119)

Lee, M. M.Y. et al. (2019) Invasive versus medical management in patients with prior coronary artery bypass surgery with a non-ST segment elevation acute coronary syndrome: a pilot randomized controlled trial. Circulation: Cardiovascular Interventions, 12(8), e007830. (doi: 10.1161/CIRCINTERVENTIONS.119.007830) (PMID:31362541)

Balmforth, C. et al. (2019) Outcomes and effect of treatment according to etiology in HFrEF: an analysis of PARADIGM-HF. JACC: Heart Failure, 7(6), pp. 457-465. (doi: 10.1016/j.jchf.2019.02.015) (PMID:31078482)

Simpson, J., Benson, L., Jhund, P.S. , Dahlström, U., McMurray, J.J.V. and Lund, L.H. (2019) "Real world" eligibility for sacubitril/valsartan in unselected heart failure patients: data from the Swedish Heart Failure Registry. Cardiovascular Drugs and Therapy, 33(3), pp. 315-322. (doi: 10.1007/s10557-019-06873-1) (PMID:30903545) (PMCID:PMC6538576)

Simpson, J. and McMurray, J. J.V. (2018) Prognostic modeling in heart failure: time for a reboot. JACC: Heart Failure, 6(6), pp. 463-464. (doi: 10.1016/j.jchf.2018.03.020) (PMID:29852930)

Lupón, J. et al. (2018) Barcelona Bio-HF Calculator Version 2.0: incorporation of angiotensin II receptor blocker neprilysin inhibitor (ARNI) and risk for heart failure hospitalization. European Journal of Heart Failure, 20(5), pp. 938-940. (doi: 10.1002/ejhf.949) (PMID:28949101)

Lee, M. M.Y. et al. (2016) Non-invasive versus invasive management in patients with prior coronary artery bypass surgery with a non-ST segment elevation acute coronary syndrome: study design of the pilot randomised controlled trial and registry (CABG-ACS). Open Heart, 3(1), e000371. (doi: 10.1136/openhrt-2015-000371) (PMID:27110377) (PMCID:PMC4838768)

Simpson, J. et al. (2015) Comparing LCZ696 with Enalapril according to baseline risk using the MAGGIC and EMPHASIS-HF risk scores. Journal of the American College of Cardiology, 66(19), pp. 2059-2071. (doi: 10.1016/j.jacc.2015.08.878) (PMID:26541915)

Simpson, J., Jackson, C. E. and Gardner, R. S. (2014) Biomarkers in mechanical circulatory support. Biomarkers in Medicine, 8(6), pp. 855-869. (doi: 10.2217/BMM.14.55)

Conference or Workshop Item

Lee, M. M.Y. et al. (2018) Non-Invasive Versus Invasive Management in Patients With Prior Coronary Artery Bypass Surgery With a Non-ST Segment Elevation Acute Coronary Syndrome: Comparisons Between the Randomized Controlled Pilot Trial and Registry. ACC.18, Orlando, FL, USA, 10-12 Mar 2018. A45. (doi: 10.1016/S0735-1097(18)30586-2)

Lee, M. M.Y. et al. (2018) Routine Non-invasive vs Invasive Management in Patients With Prior CABG With a NSTE-ACS: a Randomised Controlled Trial. British Cardiovascular Intervention Society Young Investigator Award Shortlisted Presentations, London, UK, 30 Nov 2017. A5.2-A6. (doi: 10.1136/heartjnl-2018-BCIS.9)

This list was generated on Thu Sep 26 13:04:30 2024 BST.